Chemical methods to study protein palmitoylation pathways
Chemical methods to study protein palmitoylation pathways
批准号:
9316096
负责人:
Matthew Bogyo
金额:
$8.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2018-05-31
关键词:
AcidsAffectAffinityAldehydesBindingBiochemicalBiologicalCell divisionCell physiologyCellsChemicalsChemistryCysteineDataDoseEnhancersEnzymesEventExcisionFutureGTP-Binding ProteinsGeneticGenetic ScreeningHealthHomologous GeneHumanHydrolaseHydrolysisIndividualLabelLibrariesLightLinkLipidsMethodsModificationMutateOrganellesPalmitatesPalmitic AcidsPalmitic Acylation SiteParasitesPathway interactionsPost-Translational Protein ProcessingProcessProtein SProteinsProteomicsRegulationReportingRoleSeriesSignal TransductionSignaling ProteinTechnologyTherapeuticTherapeutic AgentsTherapeutic InterventionTimeToxoplasma gondiiValidationanalogasexualbasecell motilitychemical geneticsdesignfunctional groupimaging modalityinhibitor/antagonistintercellular communicationmyristoylationnovelpalmitoyl-protein hydrolasepalmitoylationparasite invasionpathogenprenylationpreventprotein acyltransferaseprotein functionsmall molecule inhibitorsynaptic functionsynaptogenesisthioestertool
中文摘要
描述(由申请人提供):蛋白S-棕榈酰化是一种翻译后修饰(PTM),其中脂肪酰基部分(饱和16 C棕榈酸酯)通过硫酯键与靶蛋白上的半胱氨酸残基连接。与肉豆蔻酰化和异戊烯化这两个不可逆过程不同,棕榈酰化是动态和可逆的。被称为蛋白酰基转移酶(PAT)的酶将棕榈酸酯基团连接到蛋白质上,而酰基蛋白硫酯酶(APT)通过水解硫酯键来去除修饰。尽管是一个PTM,调节一系列的动态过程,包括细胞信号传导,细胞分裂和突触形成,可逆棕榈酰化的蛋白质的例子很少有记录,反映了普遍缺乏可用于研究这个动态过程的工具。我们最近发现了一类化合物,增强寄生虫病原体弓形虫宿主细胞入侵的过程。我们已经确定,这些化合物通过结合和抑制人类酰基蛋白硫酯酶1(APT 1)的寄生虫同源物发挥作用,APT 1是一种参与包括Ras、eNOS和G蛋白在内的一系列信号蛋白脱棕榈酰化的水解酶。我们的化合物直接阻断这种酶的功能,导致棕榈酰化底物的积累和寄生虫运动和细胞器分泌的改变。此外,同源性搜索和最近的报告表明,寄生虫可能表达三个额外的酰基蛋白硫酯酶。我们假设可逆棕榈酰化是T.弓形虫和其他可能的人类病原体调节重要过程,了解如何调节特定底物上棕榈酸酯基团的去除将揭示可被破坏以获得治疗效果的途径。因此,我们建议:1)确定T。2)使用化学蛋白质组学策略来鉴定由动态棕榈酰化调节的候选蛋白质底物和3)开发化学工具来验证特定脱棕榈酰化事件的重要性。该提案利用各种化学、生物化学、蛋白质组学和细胞生物学方法来实现这些目标。
英文摘要
DESCRIPTION (provided by applicant): Protein S-palmitoylation is a post-translational modification (PTM) where a fatty acyl moiety (saturated 16C palmitate) is linked via a thioester bond to a cysteine residue on target proteins. Unlike myristoylation and prenylation, which are irreversible processes, palmitoylation is dynamic and reversible. Enzymes termed protein acyltransferases (PATs) attach the palmitate group to proteins, while acyl-protein thioesterases (APTs) remove the modification by hydrolysis of the thioester bond. Despite being a PTM that regulates a range of dynamic process including cell signaling, cell division and synapse formation, very few examples of reversibly palmitoylated proteins have been documented, reflecting the general lack of tools available for studying this dynamic process. We recently identified a class of compounds that enhance the process of host cell invasion by the parasite pathogen Toxoplasma gondii. We have determined that these compounds function by binding and inhibiting the parasite homolog of human acyl-protein thioesterase 1 (APT1), a hydrolase involved in depalmitoylation of a range of signaling proteins including Ras, eNOS and G proteins. Our compounds directly block the function of this enzyme, resulting in accumulation of palmitoylated substrates and alteration of parasite motility and organelle secretion. In addition, homology search and recent reports indicate that parasites may express three additional acyl-protein thioesterases. We hypothesize that reversible palmitoylation is a key regulatory process used by T. gondii and likely other human pathogens to regulate important processes and that understanding how regulated removal of palmitate groups on specific substrates will shed light on pathways that can be disrupted for therapeutic gain. Therefore, we propose to 1) determine the repertoire of depalmitoylating enzymes in T. gondii and develop small molecule inhibitors to study their function 2) Use a chemical proteomics strategy to identify candidate protein substrates regulated by dynamic palmitoylation and 3) develop chemical tools to validate the importance of specific depalmitoylation events. This proposal makes use of diverse chemical, biochemical, proteomic and cell biological methods to accomplish these aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19
-
批准号:10377746
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2022
-
负责人:Matthew Bogyo
-
依托单位:
Covalent inhibitors of host cell entry by SARS-CoV-2 for treatment of COVID-19
-
批准号:10611435
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2022
-
负责人:Matthew Bogyo
-
依托单位:
Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases
-
批准号:10389858
-
项目类别:
-
资助金额:$50.97万
-
财政年份:2021
-
负责人:Matthew Bogyo
-
依托单位:
Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases
-
批准号:10670358
-
项目类别:
-
资助金额:$45.8万
-
财政年份:2021
-
负责人:Matthew Bogyo
-
依托单位:
Molecular Pharmacology Training Program
-
批准号:10205787
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2021
-
负责人:Matthew Bogyo
-
依托单位:
Molecular Pharmacology Training Program
-
批准号:10617732
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2021
-
负责人:Matthew Bogyo
-
依托单位:
Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases
-
批准号:10491372
-
项目类别:
-
资助金额:$49.4万
-
财政年份:2021
-
负责人:Matthew Bogyo
-
依托单位:
A rapid and inexpensive point of care diagnostic for SARS-CoV-2 infection
-
批准号:10163296
-
项目类别:
-
资助金额:$35.48万
-
财政年份:2020
-
负责人:Matthew Bogyo
-
依托单位:
Dual orthogonal fluorescent protease sensors for image guided surgery
-
批准号:10213725
-
项目类别:
-
资助金额:$36.57万
-
财政年份:2019
-
负责人:Matthew Bogyo
-
依托单位:
Dual orthogonal fluorescent protease sensors for image guided surgery
-
批准号:10018651
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2019
-
负责人:Matthew Bogyo
-
依托单位:
Dual orthogonal fluorescent protease sensors for image guided surgery
-
批准号:10457944
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2019
-
负责人:Matthew Bogyo
-
依托单位:
Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agents
-
批准号:9894800
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2018
-
负责人:Matthew Bogyo
-
依托单位:
Development of Imaging Probes for Risk Assessment of Alzheimer's Disease using Phage Display
-
批准号:10287384
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2018
-
负责人:Matthew Bogyo
-
依托单位:
Development of non-antibiotic therapeutics for Clostridium difficile infection (CDI)
-
批准号:9464655
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2017
-
负责人:Matthew Bogyo
-
依托单位:
Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria
-
批准号:9222222
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2016
-
负责人:Matthew Bogyo
-
依托单位:
Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria
-
批准号:9813820
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2016
-
负责人:Matthew Bogyo
-
依托单位:
Parasite-specific proteasome inhibitors to combat multi-drug resistant malaria
-
批准号:10062837
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2016
-
负责人:Matthew Bogyo
-
依托单位:
Multiplexed in vivo drug screening: Inhibitors of metastatic seeding
-
批准号:8772185
-
项目类别:
-
资助金额:$20.97万
-
财政年份:2014
-
负责人:Matthew Bogyo
-
依托单位:
Chemical methods to study protein palmitoylation pathways
-
批准号:8917278
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2014
-
负责人:Matthew Bogyo
-
依托单位:
Multiplexed in vivo drug screening: Inhibitors of metastatic seeding
-
批准号:8902079
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2014
-
负责人:Matthew Bogyo
-
依托单位:
海外基金